Significance of melatonin in antioxidative defense system: Reactions and products

NeuroSignals

Volumn 9, Issue 3-4, 2000, Pages 137-159

  Tan, Dun Xian ^a   Manchester, Lucien C ^a   Reiter, Russel J ^a   Qi, Wen Bo ^a   Karbownik, Malgorzata ^b   Calvoa, Juan R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidants; Free radicals; Melatonin; Metabolite; Plants; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; MELATONIN; NITRIC OXIDE; PEROXY RADICAL; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; CHEMICAL ANALYSIS; CHEMICAL REACTION; CONFERENCE PAPER; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; FREE RADICAL SCAVENGERS; HUMANS; MELATONIN; PLANTS; REACTIVE OXYGEN SPECIES;

EID: 0033910011     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014635     Document Type: Article

References (138)

1. Stohs SJ, Bagchi D: Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321-336.
2. Rollet-Labelle E, Grange MJ, Elbim C, Marquetty C, Gourgerot-Pocida-lo MA, Pasquier C: Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med 1998;24:563-572.
3. Harman D: Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
4. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623.
5. Lubec G: The hydroxyl radical: From chemistry to human disease. J Invest Med 1996;44:324-346.
6. Ahmad S: Antioxidant mechanisms of enzymes and proteins; in Ahmad S (ed): Oxidative Stress and Antioxidative Defense in Biology. New York, Chapman & Hall, 1995, pp 238-272.
7. Briviba K, Sies H: Nonenzymatic antioxidative defense system; in Frei B (ed): Natural Antioxidants in Human Health and Disease. San Diego, Academic Press, 1994, pp 107-128.
8. Boveris A, Chance B: The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen. Biochem J 1973;134:707-716.
9. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
10. Autor AP: Biosynthesis of mitochondrial manganese superoxide dismutase in Saccharomyces cerevi-siae: Precursor form of mitochondrial superoxide dismutase made in the cytoplasm. J Biol Chem 1982; 257:2713-2718.
11. Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
12. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen free radicals, transition metals and disease. Bio-chem J 1984;219:1-14.
13. Reiter RJ: The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980; 1:109-131.
14. Lerner AB, Case JD, Takahashi Y: Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc 1958;80:2587.
15. Reiter RJ: Pineal melatonin: Cell biology of its synthesis and its physiological interactions. Endocr Rev 1991;12:151-180.
16. Reiter RJ: Melatonin: The chemical expression of darkness. Mol Cell Endocrinol 1991;79:C153-C158.
17. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
18. Reiter RJ: Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998; 56:359-384.
19. Reiter RJ, Guerrero JM, Garcia JJ, Acuna-Castroviejo D: Reactive oxygen intermediates, molecular damage and aging: Relation to melatonin. Ann NY Acad Sci 1998;854: 410-454.
20. Costa EJX, Shida CS, Biaggi MH, Ito AS, Lamy-Freund MT: How melatonin interacts with lipid bilayers: A study by fluorescence and ESR spectroscopies. FEBS Lett 1997;416:103-106.
21. Shida CS, Castrucci AML, Lamy-Freund MT: High melatonin solubility in aqueous medium. J Pineal Res 1994;16:198-201.
22. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N: Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 1999;26:147-152.
23. Menendez-Pelaez A, Poeggeler B, Barlow-Walden LR, Pablos MI, Tan DX: Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993;53:572-582.
24. Hardeland R, Balzer I, Poeggeler B, Uria H, Behrmann G, Wolf R, Meyer TJ, Reiter RJ: On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res 1995;18:104-111.
25. Manchester LC, Poeggeler B, Al-vares FL, Ogden GB, Reiter RJ: Melatonin immunoreactivity in the photosynthetic prokaryote, Rhodo-spirillum rubrum: Implications for an ancient antioxidant system. Cell Mol Biol Res 1995;41:391-395.
26. Poeggeler B, Balzer I, Hardeland R, Lerchl A: Pineal hormone melatonin oscillates also in the dinoflagel-late Gonyaulax polyedra. Naturwis-senschaften 1991;78:268-269.
27. Hattori A, Migitaka H, Masayake I, Itoh M, Yamamoto K, Ohtani-Ka-neko R, Hara M, Suzuki T, Reiter RJ: Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Bio-chem Mol Biol Int 1995;35:627-634.
28. Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C, Schiwara HW, Schloot W: Melatonin in edible plants identified by radioimmunoassay and high-performance liquid chromatography-mass spectrometry. J Pineal Res 1995; 18: 28-31.
29. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castro-viejo D: A review of the evidence supporting melatonin’s role as an antioxidant. J Pineal Res 1995; 18: 1-11.
30. Reiter RJ, Tan DX, Cabrera J, D’arpa D, Sainz RM, Mayo JC, Ramos S: The oxidant/antioxidant network: Role of melatonin. Biol Signals Recept 1999;8:56-63.
31. Zang LY, Cosma G, Gardner H, Vallynathan V: Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998;1425: 469-477.
32. Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B: Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996;21:307-315.
33. Matuszak Z, Reszka K, Chignell CF: Reaction of melatonin and related indoles with hydroxyl radicals: ESR and spin trapping investigation. Free Radic Biol Med 1997;23:367-372.
34. Stasica P, Ulanski P, Rosiak JM: Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998;25:65-66.
35. Stasica P, Ulanski P, Rosiak JM: Reactions of melatonin with radicals in deoxygenated aqueous solution. J Radioanal Nucl Chem 1998; 232:107-113.
36. Poeggeler B, Reiter RJ, Hardeland R, Sewerynek E, Melchiorri D, Bar-low-Walden LR: Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox and glutathione. Neuroendocr Lett 1995;17:87-92.
37. Scaiano JC: Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J Pineal Res 1995;19:189-195.
38. Poeggeler B, Reiter RJ, Hardeland R, Tan DX, Barlow-Walden LR: Melatonin and structurally-related endogenous indoles acts as potent electron donors and radical scavenger in vitro. Redox Rep 1996;2:179-184.
39. Li XJ, Zhang LM, Gu J, Zhang AZ, Sun FY: Melatonin decreases production of hydroxyl radical during ischemia-reperfusion. Acta Pharmacol Sin 1997;18:394-396.
40. Bromme HJ, Ebelt H, Peschke D, Peschke E: Alloxan acts as a prooxidant only under reducing conditions: Influence of melatonin. Cell Mol Life Sci 1999;55:487-493.
41. Pahkla R, Zilmer M, Kullisar T, Rago L: Comparison of the antioxidant activity of melatonin and pi-noline in vitro. J Pineal Res 1998; 24:96-101.
42. Roberts JE, Hu DN, Wishart JF: Pulse radiolysis studies of melatonin and chloromelatonin. J Photochem Photobiol B 1997;42:125-132.
43. Mahal HS, Sharma HS, Mukherjee T: Antioxidant properties of melatonin: A pulse radiolysis study. Free Radic Biol Med 1999;26:557-565.
44. Ebelt H, Peschke D, Bromme HJ, Morke W, Blume R, Peschke E: Influence of melatonin on free radical induced changes in rat pancreatic belt cells in vitro. J Pineal Res 2000; 28:65-72.
45. Bromme HJ, Morke W, Peschke D, Ebelt H, Peschke E: Scavenging effect of melatonin on hydroxyl radicals generated under the influence of alloxan. J Pineal Res, in press.
46. Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Chiso J, Pappola MA: Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem 1999;274:21973-21942.
47. Schmuck A, Fuller CJ, Devaraj S, Jialal I: Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin Chem 1995;41: 1628-1632.
48. Pansarasa O, Bertorelli L, Vecchiet J, Felzani G, Marzatico F: Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. Free Radic Biol Med 1999;27:617-622.
49. Ramirez-Leon V, Kullberg S, Hjelle OP, Ottersen OP, Ulfhake B: Increased glutathione levels in neurochemically identified fibre systems in the aged rat lumbar motor nuclei. Eur J Neurosci 1999;11:2935-2948.
50. Pierpaoli W, Regelson W: Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci USA 1994;91: 787-791.
51. Anisimov VN, Mylnikov SV, Kha-vinson VK: Pineal peptide preparation epithalamin increases the lifespan of fruit flies, mice and rats. Mech Ageing Dev 1998; 103:123-132.
52. Lentner C: Physical Chemistry, Composition of Blood, Hematology, Somatometric Data Geigy Scientific Tables. West Caldwell/NJ, Ciba-Geigy, 1984, vol 3, pp 71-132.
53. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Wein-traub ST, Vijayalaxmi, Shepherd AM: A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253:614-620.
54. Seegar H, Meck AO, Lippert TH: Effect of melatonin and metabolites on cooper-mediated oxidation of flow density lipoprotein. Br J Clin Pharmacol 1997;44:283-284.
55. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Limson J, Weintraub ST, Qi WB: Melatonin directly scavenges hydrogen peroxide: A new metabolic pathway (submitted).
56. Tan DX, Manchester LC, Reiter RJ, Qi W, Zhang M, Weintraub ST, Cabrera J, Sainz RM, Mayo JC: Identification of highly elevated levels of melatonin in bone marrow: Its origin and significance. Biochim Bio-phys Acta 1999;1472:206-214.
57. Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni GJM: Melatonin synthesis in mouse and human bone marrow cells. J Pineal Res, in press.
58. Tan DX, Manchester LC, Reiter RJ, Qi W, Hanes MA, Farley NJ: High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65:2523-2529.
59. Skinner DC, Malpaux B: High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999;140:4399-4405.
60. Benot S, Goberna R, Reiter RJ, Car-cia-Maurino S, Osuna C, Guerrero JM: Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 1999;27:59-64.
61. Reiter RJ, Tan DX, Kim SJ, Manchester LC, Qi W, Garcia JJ, Cabrera JC, Ei-Sokkary G, Rouvier-Garay V: Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Aging Dev 1999;110:157-173.
62. 32P uptake in the rat. Acta Endocrinol 1959;30: 22-28.
63. Hardeland R, Reiter RJ, Poeggeler B, Tan DX: The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993;17:347-357.
64. Turjanski AG, Rosenstein RE, Es-trin DA: Reactions of melatonin and related indoles with free radicals: A computational study. J Med Chem 1998;41:3684-3689.
65. Stasica P, Paneth P, Rosiak JM: Hydroxyl radical addition to the melatonin molecule. A computational study. J Pineal Res, in press.
66. Nakagawa M, Watanabe H, Kodato S, Okajima H, Hino T, Flippen JL, Witkop B: A valid model for the mechanism of oxidation of tryptophan to formylkynurenine-25 years later. Proc Natl Acad Sci USA 1977;4:4730-4733.
67. Uchida K, Enomoto N, Itakura K, Kawakishi S: Formation of diaste-reoisomeric 3a-hydroxypyrroloin-doles from a tryptophan residue analog mediated by iron (II)-EDTA and /-ascorbate. Arch Biochem Bio-phys 1990;279:14-20.
68. Schonbaum GR, Chance B: Catalase; in Boyer PD (ed): The Enzymes, ed 2. New York, Academic Press, 1976, vol XIII, pp 363-408.
69. Oshino N, Chance B, Sies H, Bucher T: The role of H2O2 generation in perfused rat liver and the reaction of catalase compound I and hydrogen donors. Arch Biochem Biophys 1973;154:117-131.
70. Thayer WS: Adriamycin stimulated superoxide formation in submitochondrial particles. Chem Biol Interact 1977;19:250-252.
71. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleineck NL: Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res 1991;51:5993-5996.
72. Reiter RJ, Guerrero JM, Garcia JJ, Acuna-Castroviejo D: Reactive oxygen intermediates, molecular damage, and aging. Ann NY Acad Sci 1998;854:410-424.
73. Cagnoli CM, Atabay C, Kharlamova E, Manev H: Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995;18:222-226.
74. March J: Advanced Organic Chemistry, ed 4. Toronto, Wiley, 1992, pp 1-823.
75. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxynitrite. Life Sci 1997;60:PL169-PL174.
76. Cuzzocrea S, Zingarelli B, Cilad E, Hake P, Salzman AL, Szabo C: Protective effect of melatonin in carrageenan-induced models of local inflammation: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 1997; 23:106-116.
77. Cuzzocrea S, Zingarelli B, Constantino G, Caputi AP: Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J Pineal Res 1998;25:24-33.
78. Zhang H, Squadrito GL, Pryor WA: The reaction of melatonin with per-oxynitrite: Formation of melatonin radical cation and absence of stable nitrated product. Biochem Biophys Res Commun 1998;251:83-87.
79. Zhang H, Squadrito GL, Uppu R, Pryor WA: Reaction of peroxyni-trite with melatonin: A mechanistic study. Chem Res Toxicol 1999;12: 526-534.
80. Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B: Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996;21:307-315.
81. Dellegar SM, Murphy SA, Bourne AE, DiCesare JC, Purser GH: Identification of the factors affecting the rate of deactivation of hypochlorous acid by melatonin. Biochem Bio-phys Res Commun 1999;254:431-439.
82. Winkler BS, Orseli SM, Rex TS: The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Rad-ic Biol Med 1994;17:333-349.
83. Regoli F, Winston GW: Quantification of total oxidant scavenging capacity of antioxidants for peroxyni-trite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol 1999;156:96-105.
84. Soriani M, Pietraforte D, Minetti M: Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Bio-phys 1994;312:180-188.
85. Aruoma OI: Free radicals: Dietary advantages and disadvantages; in Scandalios JG (ed): Oxidative Stress and the Molecular Biology of Antioxidant Defenses. Boston, Cold Spring Harbor Laboratory Press, 1997, pp 841-860.
86. Herbert V: Does mega-C do more good than harm, or more harm than good? Nutr Today 1993;Jan/Feb 28-32.
87. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC: Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res 1993;14:151-168.
88. Gozzo A, Lesieur D, Duriez P, Fru-chart JC, Teissier E: Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model. Free Radic Biol Med 1999;26:1538-1543.
89. Fischer-Nielsen A, Poulsen HA, Loft S: 8-Hydroxydeoxyguanosine in vitro: Effects of glutathione, ascorbate, and 5-aminosalicylic acid. Free Radic Biol Med 1992; 13:121-126.
90. Peruche B, Kriegelstein J: Mechanisms of drug actions against neuronal damage caused by ischemia-An overview. Prog Neuropsycho-pharmacol Biol Psychiatry 1993;17: 21-70.
91. Tan DX, Manchester LC, Reiter RJ, Plummer BF: Cyclic 3-hydroxymel-atonin: A melatonin metabolite generated as a result of hydroxyl radical scavenging. Biol Signals Recept 1999;8:70-74.
92. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A: Lipo-polysaccharide-induced hepatotox-icity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995; 293:327-334.
93. Floreani M, Skaper SD, Facci L, Li-partiti M, Giusti P: Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB J 1997;11:1309-1315.
94. Montilla PL, Vargas JF, Tunez IF, Munoz de Agueda MC, Valdelvira ME, Cabrera ES: Oxidative stress in diabetic rats induced by streptozoto-cin: Protective effects of melatonin. J Pineal Res 1998;25:94-100.
95. Hara M, Iigo M, Ohtani-Kaneko R, Nakamura N, Suzuki T, Reiter RJ, Hirata K: Administration of melatonin and related indoles prevents exercise-induced cellular oxidative changes in rats. Biol Signals 1997;6: 90-100.
96. Chan TY, Tang PL: Characterization of antioxidant effects of melatonin and related indoleamines in vitro. J Pineal Res 1996;20:187-191.
97. Nappi AJ, Vass E: Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols. Bio-chim Biophys Acta 1997; 1336: 295-302.
98. Barsacchi R, Kusmic C, Damiani E, Carloni P, Greci L, Donato L: Vitamin E consumption induced by oxidative stress in red blood cells is enhanced by melatonin and reduced by N-acetylserotonin. Free Radic Biol Med 1998;24: 1187-1192.
99. Laranjinha J, Vieira O, Madeira V, Aleida L: Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferryl-myoglobin: Consumption vs. regeneration. Arch Biochem Biophys 1995;323:373-381.
100. Dreher F, Gabard B, Schwindt DA, Maibach HI: Topical melatonin in combination with vitamin E and C protects skin from ultraviolet-induced erythema: A human study in vivo. Br J Dermatol 1998;139:332-339.
101. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH: Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: Prevention by melatonin. J Pineal Res 1998;25:184-191.
102. Kolar J, Machackova I, Eder J, Prinsen E, van Dongen W, van Onckelen H, Illnerova H: Melatonin: Occurrence and daily rhythm in Chenopodium rubrum. Phytochemistry 1997;44:1407-1414.
103. Murch SJ, Simmons CB, Saxena PX: Melatonin in feverfew and other medical plants. Lancet 1997; 350:1598-1599.
104. Smith LK, Polle A, Rennenberg H: Glutathione; in Alscher RG, Cum-ming JR (eds): Stress Response in Plants: Adaptation and Acclimation Mechanisms. New York, Wi-ley-Liss, 1990, pp 201-217.
105. Moffat AS: Plants proving their worth in toxic metal cleanup. Science 1995;269:302-303.
106. Limson J, Nyokong T, Daya S: The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: An adsorptive voltammetric study. J Pineal Res 1998;24:15-21.
107. Susa N, Ueno S, Furukawa Y, Ueda J, Sugiyama M: Potent protective effect of melatonin on chromium (VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cul-tutres of rat hepatocytes. Toxicol Appl Pharmacol 1997; 144:377-384.
108. Kim CY, Lee MJ, Lee SM, Lee WC, Kim JS: Effect of melatonin on cadmium-induced hepatotoxic-ity in male Sprague-Dawley rats. Tohoku J Exp Med 1998; 186:205-213.
109. Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ, Viswanathan M, Zisapel N: Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998;7:195-219.
110. Blask DE, Sauer LA, Dauchy R, Holowachuk EW, Ruhoff MS: New actions of melatonin on tumor metabolism and growth. Biol Signals Recept 1999;8:49-55.
111. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 1999;59:4693-4701.
112. Brusco LI, Fainstein I, Marquez M, Cardinali DP: Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept 1999;8:126-131.
113. Fauteck J, Schmidt H, Lerchl A, Kurlemann G, Wittkowski W: Melatonin in epilepsy: First results of replacement therapy and first clinical results. Biol Signals Recept 1999;8:105-110.
114. Gilad E, Laufer M, Matzkin H, Zisapel N: Melatonin receptors in PC3 human prostate tumor cells. J Pinceal Res 1999;26:211-220.
115. Hoffmann A, Farker K, Dittgen M, Hoffmann H: A melatonin preparation with a pulsatile liberation pattern: A new form of melatonin in replacement therapy. Biol Signals Recept 1999;8:96-104.
116. Karasek M, Pawlikowski M: Antiproliferative effects of melatonin and CGP 52608. Biol Signals Recept 1999;8:75-78.
117. Kirby AW, Clayton M, Rivera P, Comperatore CA: Melatonin and the reduction or alleviation of stress. J Pineal Res 1999;27:78-85.
118. Lissoni P, Tancini G, Paolorossi F, Mandala M, Ardizzoia A, Malu-gani F, Giani L, Barni S: Chemo-neuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study. J Pineal Res 1999;26:169-173.
119. Petranka J, Baldwin W, Biermann J, Jayadev S, Barrett JC, Murphy E: The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 1999;26:129-136.
120. Skene DJ, Lockley SW, Arendt J: Melatonin in circadian sleep disorders in the blind. Biol Signals Re-cept 1999;8:90-95.
121. Shiu SY, Li L, Xu JN, Pang CS, Wong JT, Pang SF: Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: Possible involvement of MT2 (MEL1B) receptor. J Pineal Res 1999;27:183-192.
122. Wahlund B: Melatonin in psychiatric disorders-subtyping affective disorder. Biol Signals Re-cept 1999;8:120-125.
123. Zisapel N: The use of melatonin for the treatment of insomnia. Biol Signals Recept 1999;8:84-89.
124. Pless G, Frederiksen TJ, Garcia JJ, Reiter RJ: Pharmacological aspects of N-acetyl-5-methoxytryp-tamine (melatonin) and 6-me-thoxy-1,2,3,4-tetrahydro-beta-car-boline (pinoline) as antioxidants: Reduction of oxidative damage in brain region homogenates. J Pineal Res 1999;26:236-246.
125. Spadoni G, Mor M, Tarzia G: Structure-affinity relationships of indole-based melatonin analogs. Biol Signals Recept 1999;8:15-23.
126. Tarzia G, Diamantini G, Spadoni G: Indole melatonin agonists and antagonists derived by shifting the melatonin side chain from the C-3 to the N-1 or to the C-2 indole position. Biol Signals Recept 1999; 8:24-31.
127. Reiter RJ, Tang L, Garcia JJ, Mu-noz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60:2255-2271.
128. Tang PL, Xu MF, Qian ZM: Differential behaviour of cell membranes towards iron-induced oxidative damage and the effects of melatonin. Biol Signals 1997;6: 291-300.
129. Brusco LI, Marquez M, Cardinali DP: Monozygotic twins with Alzheimer’s disease treated with melatonin: Case report. J Pineal Res 1998;25:260-263.
130. Southgate GS, Daya S, Potgieter B: Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. J Chem Neuroanat 1998; 14:151-156.
131. Marchiafava PL, Longoni B: Melatonin as an antioxidant in retinal photoreceptors. J Pineal Res 1999; 26:184-189.
132. Cuzzocrea S, Tan DX, Costantino G, Mazzon E, Caputi AP, Reiter RJ: The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J 1999;13:1930-1938.
133. Morioka N, Okatani Y, Wakatsuki A: Melatonin protects against age-related DNA damage in the brains of female senescence-accelerated mice. J Pineal Res 1999;27:202-209.
134. Morishima I, Okumura K, Matsui H, Kaneko S, Numaguchi Y, Ka-wakami K, Mokuno S, Hayakawa M, Toki Y, Ito T, Hayakawa T: Zinc accumulation in Adriamycin-induced cardiomyopathy in rats: Effects of melatonin, a cardioprotective antioxidant. J Pineal Res 1999;26:204-210.
135. Pappolla MA, Chyan YJ, Poegge-ler B, Bozner P, Ghiso J, LeDoux SP, Wilson GL: Alzheimer beta-protein-mediated oxidative damage of mitochondrial DNA: Prevention by melatonin. J Pineal Res 1999;27:226-229.
136. Siu AW, Reiter RJ, To CH: Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999;27:122-128.
137. Tesoriere L, D’arpa D, Conti S, Giaccone V, Pintaudi AM, Livrea MA: Melatonin protects human red blood cells from oxidative hemolysis: New insights into the radical-scavenging activity. J Pineal Res 1999;27:95-105.
138. Vijayalaxmi, Meltz ML, Reiter RJ, Herman TS: Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice. J Pineal Res 1999;27:221-225